ONE Bio Announces 132% Year-Over-Year Sales Growth for 2010
23 February 2011 - 12:00AM
Marketwired
ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an
innovative company utilizing green process manufacturing to produce
raw chemicals and herbal extracts, natural and health supplements
and organic products, today announced preliminary unaudited
revenues of $51 million for the fiscal year ended December 31,
2010, representing an increase of 132% from $22 million for fiscal
2009.
The increase in sales was primarily due to acquisitions the
Company completed during 2009 and new products the Company launched
in 2010. Sales of the new products contributed $6.4 million,
accounting for 12% of total 2010 revenues. The new products also
yielded an average gross margin of approximately 54%.
ONE's Chemical and Herbal Extract ("CHE") division led the
Company's product launches, introducing several new products,
including Sero®, a house-branded stevia sweetener; Green Tea
Extracts, Sarcandra, and Ganoderma Tea.
"These in-demand new products, along with our core products,
position ONE for continued and sustainable growth at high margins,"
stated ONE's CEO, Marius Silvasan. "The new products launched
during 2010 and the acquisitions we completed in 2009 were our
primary sales growth drivers in 2010. Products launched during the
fiscal year also yielded a gross margin above 54%, which is higher
than the gross margin yielded by our core products. This was made
possible by our strong R&D team, which consistently examines
market trends and market data to develop innovative products."
Mr. Silvasan continued, "Just as significant is the impressive
performance of our first over-the-counter health beverage,
Ganoderma Tea, which we launched during 2010. Sales of this product
reached over $5 million in 2010, representing 26% of our
nutraceutical sales. This further validates our focus on the
development of more OTC products that utilize our raw
materials."
About ONE Bio, Corp. ONE Bio, Corp.
("ONE") (OTCBB: ONBI) (www.onehcorp.com), headquartered in Miami,
FL, is an innovative company utilizing patented green process
manufacturing to produce raw chemicals and herbal extracts, natural
supplements and organic products. ONE is focused on the Asia
Pacific region and the Unites States. Key products include widely
recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic
fertilizers, and organic bamboo health food and beverages. ONE has
experienced solid organic growth driven by a robust demand for its
products in China, Japan and the United States.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact: Jeanne Chan Senior VP Tel. +888.676.4445
jchan@onehcorp.com Contact: Investor Relations & Corporate
Communications 888-676-4445 ir@onehcorp.com
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jun 2024 to Jul 2024
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jul 2023 to Jul 2024